Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule-associated scaffold protein 2 (MTUS2) is a cytoskeletal-associated protein involved in binding microtubules and protein homodimerization[1][4][6]. It localizes to the centrosome, cytoplasmic microtubule, intercellular bridge, and nucleus, and is implicated in regulating microtubule dynamics, particularly at the growing distal tips of microtubules[1][4][6]. MTUS2 interacts with proteins such as MAPRE1 and may target the microtubule depolymerase KIF2C, suggesting a functional role in controlling microtubule structure and dynamics during cell division and migration[6]. While annotated as a tumor suppressor candidate based on its name and some disease associations, its direct use as a therapeutic target is not established, and no drugs are listed as acting on this protein[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule-associated scaffold protein 2 (MTUS2).